DK247586A - Fremgangsmaade til isolering og rensning af hepatitis b overfladeantigen - Google Patents

Fremgangsmaade til isolering og rensning af hepatitis b overfladeantigen Download PDF

Info

Publication number
DK247586A
DK247586A DK247586A DK247586A DK247586A DK 247586 A DK247586 A DK 247586A DK 247586 A DK247586 A DK 247586A DK 247586 A DK247586 A DK 247586A DK 247586 A DK247586 A DK 247586A
Authority
DK
Denmark
Prior art keywords
hepatitis
insulating
cleaning
procedure
surface antigen
Prior art date
Application number
DK247586A
Other languages
Danish (da)
English (en)
Other versions
DK247586D0 (da
Inventor
Frans Van Wijnendaele
Guy Simonet
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of DK247586D0 publication Critical patent/DK247586D0/da
Publication of DK247586A publication Critical patent/DK247586A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Insulated Conductors (AREA)
  • Magnetic Heads (AREA)
  • Adornments (AREA)
DK247586A 1985-05-30 1986-05-27 Fremgangsmaade til isolering og rensning af hepatitis b overfladeantigen DK247586A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/739,415 US4649192A (en) 1985-05-30 1985-05-30 Method for the isolation and purification of hepatitis B surface antigen using polysorbate

Publications (2)

Publication Number Publication Date
DK247586D0 DK247586D0 (da) 1986-05-27
DK247586A true DK247586A (da) 1986-12-01

Family

ID=24972199

Family Applications (1)

Application Number Title Priority Date Filing Date
DK247586A DK247586A (da) 1985-05-30 1986-05-27 Fremgangsmaade til isolering og rensning af hepatitis b overfladeantigen

Country Status (12)

Country Link
US (1) US4649192A (cs)
EP (1) EP0204680B1 (cs)
JP (1) JPS61280438A (cs)
AT (1) ATE42679T1 (cs)
AU (1) AU589331B2 (cs)
CA (1) CA1259922A (cs)
DE (1) DE3663108D1 (cs)
DK (1) DK247586A (cs)
ES (1) ES8706444A1 (cs)
GR (1) GR861357B (cs)
PT (1) PT82644B (cs)
ZA (1) ZA863935B (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
EP0232410A4 (en) * 1985-08-15 1988-01-25 Amgen CLEAVAGE PROCESS AND BUFFER FOR THE EXTRACTION OF HEPATITIS B SURFACE ANTIGENS FROM YEAR CELLS.
US4742158A (en) * 1986-04-25 1988-05-03 Merck & Co., Inc. Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
RU1389060C (ru) * 1986-08-13 1993-06-30 Институт иммунологии Способ получени рекомбинатной вакцины к гепатиту В
US4683293A (en) * 1986-10-20 1987-07-28 Phillips Petroleum Company Purification of pichia produced lipophilic proteins
ATE91304T1 (de) * 1987-02-27 1993-07-15 Merck & Co Inc Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.
US5026828A (en) * 1987-02-27 1991-06-25 Merck & Co., Inc. Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast
JP2758184B2 (ja) * 1987-06-22 1998-05-28 メデバ ホールディングス ベスローテン ベノートスハップ 肝炎ｂ表面抗原ワクチン
US4883865A (en) * 1987-09-30 1989-11-28 Merck & Co. Inc. Recovery of pres2+s antigen
US5004688A (en) * 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells
CA2096650A1 (en) * 1991-09-18 1993-03-21 Keith E. Langley Hepatitis b vaccine formulation incorporating a bile acid salt
KR960023066A (ko) * 1994-12-10 1996-07-18 성재갑 전에스 (s) 2 펩티드 함유 비 (b) 형 간염 표면항원의 정제 방법
UA79735C2 (uk) * 2000-08-10 2007-07-25 Глаксосмітклайн Байолоджікалз С.А. Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
US20040057969A1 (en) * 2002-09-20 2004-03-25 Smith Mark L Compositions containing stabilized hepatitis antigen and methods of their use
EP1909830B1 (en) * 2005-08-02 2011-09-28 Novartis Vaccines and Diagnostics S.r.l. Reducing interference between oil-containing adjuvants and surfactant-containing antigens
AU2007249242B2 (en) 2006-05-11 2014-02-27 Arbor Vita Corporation Method of protein extraction from cells
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
CN111511800B (zh) 2017-10-30 2023-11-28 武田药品工业株式会社 灭活脂包膜病毒的环境相容性去污剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
US4113712A (en) * 1976-03-08 1978-09-12 The Green Cross Corporation HBsAG Particle composed of single polypeptide subunits and the preparation procedure
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
US4234564A (en) * 1977-12-19 1980-11-18 Merck & Co., Inc. Hepatitis B core antigen composition
US4315919A (en) * 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
GR76274B (cs) * 1981-08-04 1984-08-04 Univ California
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
EP0135435A3 (en) * 1983-08-22 1987-03-25 Merck & Co. Inc. Immunogenic hbsag derived from transformed yeast
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法

Also Published As

Publication number Publication date
US4649192A (en) 1987-03-10
ATE42679T1 (de) 1989-05-15
DE3663108D1 (en) 1989-06-08
EP0204680A3 (en) 1987-01-14
PT82644B (pt) 1988-03-03
PT82644A (en) 1986-06-01
CA1259922A (en) 1989-09-26
ZA863935B (en) 1987-03-25
ES555442A0 (es) 1987-07-01
GR861357B (en) 1986-09-25
JPH0450294B2 (cs) 1992-08-13
JPS61280438A (ja) 1986-12-11
ES8706444A1 (es) 1987-07-01
EP0204680A2 (fr) 1986-12-10
AU5790686A (en) 1986-12-04
DK247586D0 (da) 1986-05-27
EP0204680B1 (fr) 1989-05-03
AU589331B2 (en) 1989-10-05

Similar Documents

Publication Publication Date Title
DK247586D0 (da) Fremgangsmaade til isolering og rensning af hepatitis b overfladeantigen
WO1999062526A3 (en) Use of genetically engineered antibodies to cd38 to treat multiple myeloma
NO179703C (no) Fremgangsmåte for å belegge husholdningsgjenstander med et antivedhengningssjikt, og anvendelse av fremgangsmåten
DK0835663T3 (da) Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener
ATE306939T1 (de) Mehrstufiger kaskade-erhöhungsimpfstoff
NO863535L (no) Linseholder, saerlig holder for brilleglass som skal rengjoeres og deretter paafoeres belegg.
DE3474775D1 (en) Method for purification of hepatitis b virus surface antigen
DK164846C (da) Mikrobiologisk ren kultur af en infektioes bronkitisvirusstamme
DK364286D0 (da) Varicella-zoster virus (vzv) ga, gb og gc glycoproteiner i renset, ikke-denatureret, serologisk aktiv form og fremgangsmaade til proevning for tilstedevaerelsen af antistoffer over for disse
IT8368200A0 (it) Tappo per bottiglia di vino realizzato con il metodo champenois
AU1493995A (en) Monoclonal antibody
DK162604C (da) Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel
EA199800332A1 (ru) Способ очистки алкоксилированных жиров
DK66693D0 (da) Svovlsorbentmateriale, fremgangsmaade til dets fremstilling samt fremgangsmaade til reduktion af svovloxidkoncentrationen i emissionsgasser ved blanding af disse med svovlsorbentmaterialet
DK216387D0 (da) Apparat til rensning af vaegge, lofter og andre flader
AU1439195A (en) Monoclonal antibodies to hepatitis e virus and methods for using same
FI823476A7 (fi) Menetelmä ja laitteisto energiakulutuksen minimoimiseksi pelkistettäessä rautaoksidia pelkistäpelkistävillä kaasuilla.
FI95726C (fi) Diagnostiset menetelmät ja määrityssarjat, joissa käytetään yhdistelmä-DNA-tekniikalla muodostettua hepatitis B -viruksen pinta-antigeenia
FI921418A7 (fi) Laite ja menetelmä kamiinoiden ja niitä vastaavien muiden laitteiden lämmitystehon parantamiseksi
IT9040100A0 (it) Banco di lavoro con autocaricamento di grandi lastre di vetro
ATE38152T1 (de) Verfahren zur reinigung des hepatitis-b-virusoberfl|chenantigens.
BR6301255U (pt) Vitral em madeira

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment